Cryomass Technologies

Cryomass Technologies EBITDA per Employee

The EBITDA per Employee of Cryomass Technologies (CRYM) as of Nov 19, 2026 is -934,975.67 USD. In the previous year, EBITDA per Employee was -1.69 M USD — a change of -44.74% (higher).

EBITDA per Employee

-934,975.67USD

YoY

-44.74%

Last updated:

EBITDA per Employee of Cryomass Technologies is 2023 -934,975.67 USD. EBITDA per Employee of Cryomass Technologies was 2022 -1.69 M USD. It decreases by -44.74% higher compared to the previous year.

The Cryomass Technologies EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2016
-8,333.33 USD
Jan 1, 2017
-8,645.67 USD
Jan 1, 2018
-56,104.33 USD
Jan 1, 2019
-503,420.67 USD
Jan 1, 2020
-1.09 M USD
Jan 1, 2021
-1.33 M USD
Jan 1, 2022
-1.69 M USD
Jan 1, 2023
-934,975.67 USD
The Cryomass Technologies EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-934,975.67USD-44.74%
-1.69 MUSD+27.67%
-1.33 MUSD+21.68%
-1.09 MUSD+116.35%
-503,420.67USD+797.29%
-56,104.33USD+548.93%
-8,645.67USD+3.75%
-8,333.33USD+150.00%
-3,333.33USD-33.33%
-5,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cryomass Technologies Stock analysis

What does Cryomass Technologies do? CryoMass Technologies, Inc. operates medical marijuana dispensaries and related businesses, leveraging patented technology that utilizes liquid nitrogen to separate, collect, and protect high-value compounds from harvested plants. The firm owns a Trichome Separation unit, known as the CryoMass patented liquid nitrogen system, which is optimized for capturing fully intact cannabis and hemp trichomes along with terpenes. This system stabilizes and collects trichomes at harvest, preventing wasteful loss and functioning effectively within minutes after plants are cut or on fresh frozen and dried plant parts including trim. The company generates revenue by selling its proprietary Trichome Separation system to entities involved in the cultivation and processing of cannabis and hemp. By offering a solution that efficiently captures valuable compounds from various plant states, CryoMass Technologies targets customers seeking to maximize yield and quality in the medical marijuana sector. The business model relies on the unique capabilities of its liquid nitrogen technology to provide a superior alternative to traditional extraction methods, appealing to dispensaries and related businesses looking to enhance their operational efficiency and product integrity. Cryomass Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cryomass Technologies stock

EBITDA per Employee of Cryomass Technologies is -934,975.67 USD in 2023.

EBITDA per Employee of Cryomass Technologies changed from -1.69 M USD to -934,975.67 USD, representing a -44.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Cryomass Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Cryomass Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Cryomass Technologies

All Key Metrics — Cryomass Technologies